Dermatology Times: March 16, 2025
Across
- 3. L'Oréal’s recalled product due to benzene concerns
- 5. Novartis’ treatment (brand name) with flexible dosing for hidradenitis suppurativa
- 6. This expert (last name) reviewed the evolving role of antibiotics, emphasizing antibiotic stewardship at AAD 2025
- 7. Brand name biologic treatment discussed by Jeff Stark, MD, for psoriasis and HS
- 9. This organization (abbreviated) hosts its Chicago meeting, "Living Well with Eczema" this week
Down
- 1. Investigational non-invasive therapy for BCC with promising interim results
- 2. Karan Lal, DO, addressed its complications and safety at AAD 2025
- 3. This company’s newly-launched "Derm Difference" campaign celebrates dermatologists
- 4. Biomarker potentially linking diet to acne severity, per recent analysis
- 8. Surgical technique outperforming wide local excision in SCC control rates